Literature DB >> 4157344

Evaluation of two standardized disk methods for testing antimicrobial susceptibility of Pseudomonas aeruginosa and of the Enterobacteriaceae.

A L Barry, L J Effinger.   

Abstract

Two standardized disk diffusion susceptibility testing methods were compared using Pseudomonas aeruginosa and members of the Enterobacteriaceae. The standard Bauer-Kirby method and the agar overlay method of Barry et al. were compared using carbenicillin (50- and 100-mug disks), gentamicin, polymyxin B, and colistin sulfate. Both methods gave nearly comparable zone sizes with the enteric bacilli. However, with P. aeruginosa the agar overlay method gave zones 1 to 2 mm smaller than the Bauer-Kirby method with all drugs except gentamicin. In spite of these small differences, further examination of minimal inhibitory concentration-zone size correlations indicated that the same interpretive zone standards can be applied to either diffusion technique. For testing carbenicillin against Pseudomonas sp., 50-mug disks were unsatisfactory, especially with the agar overlay method; 100-mug disks were far superior with both methods.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4157344      PMCID: PMC444670          DOI: 10.1128/AAC.6.4.452

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Inhibitor of antibiotics in bacteriologic agar.

Authors:  C M Kunin; W P Edmondson
Journal:  Proc Soc Exp Biol Med       Date:  1968-10

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

3.  In vitro activity of carbenicillin against Pseudomonas using the disc diffusion method.

Authors:  J A Washington; M M Hall; C J Fausch; K L Brackin
Journal:  Mayo Clin Proc       Date:  1973-10       Impact factor: 7.616

4.  Pseudomonas resistance due to inactivated susceptibility disks.

Authors:  L J Griffith
Journal:  Antimicrob Agents Chemother       Date:  1973-12       Impact factor: 5.191

5.  Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin.

Authors:  A A Medeiros; T F O'Brien; W E Wacker; N F Yulug
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

6.  Carbenicillin: a clinical and laboratory evaluation.

Authors:  M I Marks; T C Eickhoff
Journal:  Ann Intern Med       Date:  1970-08       Impact factor: 25.391

7.  An improved single-disk method for testing the antibiotic susceptibility of rapidly-growing pathogens.

Authors:  A L Barry; F Garcia; L D Thrupp
Journal:  Am J Clin Pathol       Date:  1970-02       Impact factor: 2.493

8.  Comparison and evaluation of carbenicillin disks in diffusion susceptibility testing.

Authors:  J M Matsen; M E Lund; D C Brooker
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

9.  Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin.

Authors:  L P Garrod; P M Waterworth
Journal:  J Clin Pathol       Date:  1969-09       Impact factor: 3.411

  9 in total
  3 in total

1.  Colistin susceptibility testing: evaluation of reliability for cystic fibrosis isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia.

Authors:  Samuel M Moskowitz; Elizabeth Garber; Yunhua Chen; Sarah A Clock; Setareh Tabibi; Amanda K Miller; Michael Doctor; Lisa Saiman
Journal:  J Antimicrob Chemother       Date:  2010-04-29       Impact factor: 5.790

2.  Disk diffusion and serial dilution tests of susceptibility of some pathogenic gram-negative bacilli and enterococci to carbenicillin and ampicillin.

Authors:  C Garner; B Rosner; M Finland
Journal:  Antimicrob Agents Chemother       Date:  1975-08       Impact factor: 5.191

3.  Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli.

Authors:  Janet A Hindler; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2013-03-13       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.